Table 3.

Correlation between miRNA‐1247‐5p, miRNA‐301b‐3p, miRNA‐105‐5p expression and clinicopathological characteristics of lung cancer patients

		miRNA‐1247‐5p			miRNA‐301b‐3p			miRNA‐105‐5p
Characteristics	Cases No. (%)	Low	High	P‐value*	Low	High	P‐value*	Low	High	P‐value*
Gender
Male	91 (59.1)	46	45	0.87	41	50	0.14	42	49	0.251
Female	63 (40.9)	31	32		36	27		35	28
Age (years)
<62	73 (47.4)	39	34	0.42	38	35	0.628	37	36	0.872
≥62	81 (52.6)	38	43		39	42		40	41
Smoking
No	99 (64.3)	48	51	0.614	50	49	0.866	51	48	0.614
Yes	55 (35.7)	29	26		27	28		26	29
Drinking
No	112 (72.7)	53	59	0.278	54	58	0.469	57	55	0.717
Yes	42 (27.3)	24	18		23	19		20	22
Histology
NSCLC
AC	108 (70.1)	55	53	0.407	56	52	0.223	57	51	0.189
SCC	35 (22.7)	15	20		14	21		14	21
Others	11 (7.1)	4	3		4	3		4	3
Tumor size
<8.788 cm3	65 (42.2)	36	29	0.256	35	30	0.337	33	32	0.664
≥8.788 cm3	66 (42.9)	30	36		30	36		31	35
Unknown	23 (14.9)
T stage
Tis	2 (1.3)	0	2	0.562	0	2	0.587	0	2	0.528
T1	50 (32.5)	27	23		26	24		26	24
T2	46 (29.9)	22	24		21	25		19	27
T3	22 (14.3)	12	10		12	10		11	11
T4	23 (14.9)	10	13		10	13		12	11
Unknown	11 (7.1)
TNM stage
Stage 0	2 (1.3)	0	2	0.075	0	2	0.273	0	2	0.481
Stage I	39 (25.3)	20	19		19	20		19	20
Stage II	12 (7.8)	10	2		9	3		8	4
Stage III	32 (20.8)	13	19		15	17		15	17
Stage IV	62 (40.3)	32	30		31	31		31	31
Unknown	7 (4.5)
Lymph node metastasis
No	56 (36.4)	30	26	0.536	28	28	0.84	26	30	0.726
Yes	87 (56.5)	42	45		42	45		43	44
Unknown	11 (7.1)
Distant metastasis
No	85 (55.2)	43	42	0.902	43	42	0.944	42	43	0.944
Yes	62 (40.3)	32	30		31	31		31	31
Unknown	7(4.5)

^* Chi‐square test was used.